Hempseed extract protected rat kidneys from high-cholesterol damage better than statins

In rats with high-fat diet-induced high cholesterol, hempseed lipid extract improved kidney health markers and reduced inflammation more safely than the statin simvastatin.

Kaur, Simarpreet et al.·Clinical biochemistry·2021·Preliminary EvidenceAnimal StudyAnimal Study
RTHC-03234Animal StudyPreliminary Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Hempseed lipid extract (HEMP) improved lipid profiles and morphological signs of high cholesterol, and was safer than simvastatin for liver and kidney function markers. HEMP positively modulated oxidative stress markers, restored renal architecture, and activated anti-inflammatory resolution pathways (Cox-1/2, PGDS, PGES). HEMP also modulated lipid metabolism mediators (APO-B/E).

Key Numbers

Rat model with high-fat diet. HEMP improved lipid profiles and was safer than simvastatin for hepatic and renal function markers. HEMP modulated Cox-1/2, PGDS, PGES inflammatory pathways and APO-B/E lipid metabolism mediators.

How They Did This

Rat study using high-fat diet to induce hypercholesterolemia. Compared hempseed lipid extract to simvastatin and controls. Assessed lipid profiles, renal function markers, kidney histopathology, oxidative stress markers, and inflammatory pathway expression.

Why This Research Matters

Statins, while effective for cholesterol, can cause kidney problems in some patients. If hempseed extracts can manage cholesterol-related kidney damage without statin side effects, it could offer a complementary or alternative approach for certain patients.

The Bigger Picture

Hempseed (from Cannabis sativa) is nutritionally rich in omega fatty acids and proteins. This study adds kidney-protective effects to its known nutritional benefits, though the leap from rat studies to clinical recommendations requires substantial additional research.

What This Study Doesn't Tell Us

Rat model may not translate to humans. Hempseed lipid extract composition can vary. No dose-response analysis. Short-term study. Cannot compare to the extensive human evidence base for statins.

Questions This Raises

  • ?Would hempseed extracts show similar kidney-protective effects in humans?
  • ?What specific hempseed compounds drive the anti-inflammatory effects?
  • ?Could hempseed supplements complement rather than replace statins?

Trust & Context

Key Stat:
Hempseed extract was safer than simvastatin for kidney and liver markers
Evidence Grade:
Single animal study. Interesting preliminary finding but far from clinical applicability.
Study Age:
2021 preclinical rat study.
Original Title:
Hempseed (Cannabis sativa) offers effective alternative over statins in ameliorating hypercholesterolemia associated nephropathy.
Published In:
Clinical biochemistry, 93, 104-111 (2021)
Database ID:
RTHC-03234

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Can hempseed replace statins?

This rat study showed promising results, but it cannot support replacing statins in humans. Statins have decades of clinical evidence, while hempseed kidney-protective effects are only demonstrated in animals.

Is this about marijuana or hemp?

This study used hempseed from Cannabis sativa, which is the same plant species as marijuana but the seeds do not contain significant levels of THC. The focus was on the nutritional lipid content of the seeds.

Read More on RethinkTHC

Cite This Study

RTHC-03234·https://rethinkthc.com/research/RTHC-03234

APA

Kaur, Simarpreet; Garg, Ayushi; Kaushal, Naveen. (2021). Hempseed (Cannabis sativa) offers effective alternative over statins in ameliorating hypercholesterolemia associated nephropathy.. Clinical biochemistry, 93, 104-111. https://doi.org/10.1016/j.clinbiochem.2021.04.008

MLA

Kaur, Simarpreet, et al. "Hempseed (Cannabis sativa) offers effective alternative over statins in ameliorating hypercholesterolemia associated nephropathy.." Clinical biochemistry, 2021. https://doi.org/10.1016/j.clinbiochem.2021.04.008

RethinkTHC

RethinkTHC Research Database. "Hempseed (Cannabis sativa) offers effective alternative over..." RTHC-03234. Retrieved from https://rethinkthc.com/research/kaur-2021-hempseed-cannabis-sativa-offers

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.